RxDoctor Payments Data

Bethany Jacobs, PA

Physician Assistant · Millersville, PANPI 1790294288

Payments from drug & device makers

$897in general payments, 2019–2025

Across 53 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$382
  • Amarin Pharma, Inc.$145
  • Novo Nordisk$90
  • AstraZeneca$51
  • GSK$51
  • Boehringer Ingelheim$40
  • plus $138 from 7 others

What the payments were for

  • Food & beverage$85896%
  • Education$394%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$897 in reported general payments places this provider in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$50,157
Medicare patients
270
Services billed
837

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$41,135
EliquisApixaban33$39,356
TrulicityDulaglutide18$20,594
JanuviaSitagliptin Phosphate20$16,594
XareltoRivaroxaban20$15,661
MyrbetriqMirabegron11$11,771
InvokanaCanagliflozin12$10,043
Combivent RespimatIpratropium/Albuterol Sulfate12$8,620
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,615
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$4,623
ShingrixVaricella-Zoster Ge/As01b/Pf13$2,841
Omeprazole131$2,055
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,693
Losartan Potassium119$1,532
Atorvastatin Calcium187$1,466

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$90$41,13545 claims
Lilly USA, LLCTrulicity$36$20,59418 claims
Astellas Pharma US IncMyrbetriq$16$11,77111 claims
Boehringer IngelheimCombivent Respimat$40$8,62012 claims
AstraZenecaBreztri Aerosphere$51$7,61512 claims
GSKShingrix$51$2,84113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Millersville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →